Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Infections and Infectious Diseases | Family Medicine

Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 Last 

Arizona

Tucson Arizona
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

California

University of California San Diego Division of Gastroenterology
La Jolla California 92093

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

La Jolla California
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Los Angeles California
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

North County Gastroenterology Medical Group and Alliance Clinical Research
Oceanside California 92056

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Homan A Zadeh, MD, MPH
Palm Springs California 92262

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

View More »

Stanford University School of Medicine
Palo Alto California 94305
Updated

A Phase 2 clinical study for patients with Colitis, Ulcerative

Hope Square Surgical Center
Rancho Mirage California 92270

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Clinical Applications Laboratories, Inc.
San Diego California 92103

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

University of California San Francisco
San Francisco California 94115

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Santa Monica California
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Colorado

Lone Tree Colorado
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Connecticut

Endoscopy Center of Connecticut, LLC
Giolford Connecticut 06437

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Endoscopy Center of Connecticut, LLC
Hamden Connecticut 06518

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Medical Research Center of Connecticut, LLC
Hamden Connecticut 06518

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Gastroenterology Center of Connecticut, PC
Hamden Connecticut 06518

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Connecticut Children's Medical Center
Hartford Connecticut 06106

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease

View More »

Yale University
New Haven Connecticut 06510
Updated

A Phase 2 clinical study for patients with Colitis, Ulcerative

Florida

Boca Raton Florida
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

University of Florida and Shands
Gainesville Florida 32610

A clinical study for patients with Inflammatory Bowel Disease or Glycogen Storage Disease Type Ia

Gainesville Florida
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Jacksonville Florida
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Largo Florida
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

View More »

University of Miami
Miami Florida 33136

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Miami Florida
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Naples Florida
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Orange Park Surgery Center
Orange Park Florida 32073

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

North Florida Gastroenterology Research, LLC
Orange Park Florida 32073

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Endoscopy Center
Port Orange Florida 32127

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Port Orange Urgent Care
Port Orange Florida 32127

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Advanced Medical Research Center
Port Orange Florida 32127

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Port Orange Florida
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Shafran Gastroenterology Center
Winter Park Florida 32789

Patients are needed to participate in a clinical research study evaluating certolizumab pegol for the treatment of Crohn's Disease

Winter Park Florida
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Florida Medical Clinic, P.A.
Zephyrhills Florida 33542

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Florida Medical Clinic, P.A.
Zephyrhills Florida 335452

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Georgia

Georgia Endoscopy Center
Alpharetta Georgia 30005

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Athens Georgia
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

GI Consultants
Atlanta Georgia 30342

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Atlanta Georgia
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Decatur Georgia
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

View More »

Emory Healthcare Heart Center
Johns Creek Georgia 30097

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Gastroenterology Associates of Central Georgia, LLC
Macon Georgia 31201

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Macon Georgia
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Johns Creek Diagnostic Center
Suwanee Georgia 30024

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Atlanta Gastroenterology Associates
Suwanee Georgia 30024

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Idaho

Idaho Falls Idaho
Updated

Patients are needed to participate in a clinical research study of Group 3: ustekinumab approximately 6 mg/kg, Group 1: Placebo and Group 2 ustekinumab 130 mg to evaluate Crohn's Disease, Inflammatory Bowel Disease, IBD or Colitis

Illinois

University of Chicago Medicine
Chicago Illinois 60637

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Rush University Medical Center
Chicago Illinois 60612

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

First 1 2 3 4 5 6 7 8 9 Last